Rocket Lab (RKLB) is back in the spotlight after record first quarter 2026 earnings, with revenue of US$200.35 million, its largest multi year launch contract to date, and sharply higher guidance that has lifted investor interest.

The earnings surprise and multi year launch deal have coincided with powerful momentum in the stock, with a 1 day share price return of 34.22% and a 30 day share price return of 54.99%. The 1 year total shareholder return is very large and reflects how rapidly sentiment around Rocket Lab has shifted.

If you are watching how space and defense stories like Rocket Lab are moving, it can be useful to scan other AI related opportunities using our screener of 31 AI small caps

After such a sharp rerating, Rocket Lab now trades above the current average analyst target and screens as fully valued on intrinsic metrics. The key question is whether recent momentum leaves any upside, or if the market is already pricing in future growth.

Most Popular Narrative: 7.8% Overvalued

Rocket Lab’s most followed narrative pegs fair value at about $98 per share, which sits below the last close of $105.47 and frames the current premium.

Since my original post, RKLB has continued to expand its space systems business, including through acquisitions and raising more capital. Its Neutron rocket is still largely on schedule; and as expected, no major new players have arrived to take RKLBs #2 spot in space launch. This all means Rocket Lab's revenue can be expected to increase faster (though in a very lumpy manner, not the smooth curves that SimplyWallSt's valuator produces), reaching ~$44b by 2035, equivalent to around 5% market share of the ~$800B space 'backbone' economy. The new acquisitions and prevailingly limited competition mean future net profit margins can be expected to be higher before, now estimated to be 20% for net earnings of ~$9B.

Curious how a projected shift from losses to sizeable earnings and a premium profit margin ties back to that $98 fair value anchor? The narrative leans on ambitious revenue expansion, rising profitability and a valuation multiple usually reserved for established leaders in fast growing fields. Want to see which assumptions do the heavy lifting in that model and how they justify paying above today’s analyst target?

Result: Fair Value of $98 (OVERVALUED)

However, this hinges on Neutron reaching commercial success and Rocket Lab moving from a net loss of US$182.62 million to sustained profitability, without major execution setbacks.

Next Steps

With sentiment clearly divided between the upside story and the execution risks, it makes sense to move fast and stress test the underlying data yourself using the full breakdown of 1 key reward and 3 important warning signs

Looking for more investment ideas?

If you stop with just Rocket Lab, you could miss other compelling setups. Take a few minutes to scan fresh ideas that match the way you like to invest.

• Target quality at a discount by checking companies that currently look attractively priced on fundamentals with the help of 51 high quality undervalued stocks.
• Strengthen your income stream by reviewing stocks that offer higher yields and resilient payouts through the 12 dividend fortresses.
• Dial down risk by focusing on businesses with robust finances using the solid balance sheet and fundamentals stocks screener (44 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.